Melanie Ott, MD, PhD
The novel coronavirus SARS-CoV-2 has spread rapidly worldwide, and caused more than 1.5 million deaths so far. In this seminar, Melanie Ott will describe her lab’s most recent work elucidating the biology of the virus, and how that might lead to novel therapies for COVID-19.
Melanie Ott’s team focuses on virus-host cell interactions. They work traditionally on three viruses—HIV, hepatitis C (HCV), and Zika—and three biological processes—transcription, metabolism, and immune aging. Most recently, the group has expanded these efforts to include SARS-CoV-2, and has made rapid advancements in both unraveling the biology of how the pandemic virus causes human disease and the development of a novel diagnostic test.
Gladstone Science Talks allow investigators to share the latest research from their laboratories. These talks are open to the broader Gladstone community.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.